An External Validation of the Pathologic Fracture Mortality Index for Predicting 30-day Postoperative Morbidity Using 978 Institutional Patients
None of the indices reached the ideal AUC of 0.80 for any morbidity type, emphasizing the need for refinement. Updating these tools with contemporary data and exploring new prognostic factors is critical to improve morbidity risk stratification in metastatic bone disease.
Authors
- Nicole F. Bell (ORCID: https://orcid.org/0000-0002-5805-9828)
- Marilee J. Clunk (ORCID: https://orcid.org/0000-0001-9577-3716)
- Santiago A. Lozano‐Calderón (ORCID: https://orcid.org/0000-0002-0681-9004)
- Joseph O. Werenski (ORCID: https://orcid.org/0009-0003-9177-6874)
- Ryan Krueger (ORCID: https://orcid.org/0000-0001-6856-0248)
- Alisha Sodhi (ORCID: https://orcid.org/0000-0003-3879-3344)
- Olivier Q. Groot (ORCID: https://orcid.org/0000-0002-5091-3110)
- Adam S. Levin (ORCID: https://orcid.org/0000-0003-0450-7821)
- Marie W Su
- Ruhi Patil
Institutions
- Johns Hopkins University (US)
- AdventHealth Orlando (US)
- Committee on Publication Ethics (GB)
- Center for Orthopaedics (US)
Publication Details
- Journal
- Journal of the American Academy of Orthopaedic Surgeons
- Published
- 2025-04-01
- DOI
- https://doi.org/10.5435/jaaos-d-24-01131
- Citations
- 1
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 2.01